Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data
New York, Feb 7, 2026, 11:00 EST — Market closed. Johnson & Johnson (JNJ) shares ended Friday higher after a New Jersey appeals court sidelined a prominent plaintiffs’ firm from a chunk of the company’s talc litigation. The stock closed up 0.9% at $239.99, near the session high, on volume of about 8.3 million shares. (Yahoo Finance) The timing matters because the talc docket remains the company’s biggest headline risk and one of the hardest variables for investors to price. Courtroom developments can move the stock even when the underlying drug-and-device business is steady. J&J is also trying to keep